Company / Working Capital
Innoviva, Inc. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$677.8M
FY2025
5-year range
$306.1M / $677.8M
FY2021-FY2025
Trend
+113.0%
vs FY2024
Sector context
#64 of 213
Health Care
What the data says
At $678M, Innoviva, Inc.'s working capital ranks #64 of 213 in the Health Care sector. Working Capital has fluctuated over the past 10 years, ranging from $166M in FY2017 to $678M in FY2025.
Based on SEC 10-K filings.
$678M in FY2025 with a 5-year CAGR of +15.1%.
Improved from $306M to $678M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +30.0%
- 5-Year CAGR
- +15.1%
- 10-Year CAGR
- -
Sector benchmark
#64 of 213 in Health CareTop 30% of 213This company $677.8M Sector average $934.6M
▼
-27.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +15.1%, indicating consistent growth.
- In FY2025, working capital increased 113.0% year-over-year.
- Ranks #64 out of 213 companies in the Health Care sector.
- Lowest working capital in the period was in FY2017.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $677.8M | +113.0% |
| FY2024 | $318.2M | +4.0% |
| FY2023 | $306.1M | -0.8% |
| FY2022 | $308.5M | +0.2% |
| FY2021 | $307.9M | -8.4% |
| FY2020 | $335.9M | -21.1% |
| FY2019 | $425.9M | +120.3% |
| FY2018 | $193.3M | +16.7% |
| FY2017 | $165.6M | -6.9% |
| FY2016 | $178.0M | -11.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026